Detection of the emerging rotavirus G12P[8] genotype at high frequency in brazil in 2014: Successive replacement of predominant strains after vaccine introduction

被引:25
|
作者
Luchs, Adriana [1 ]
Cilli, Audrey [1 ]
Morillo, Simone Guadagnucci [1 ]
Gregorio, Debora de Souza [1 ]
Farias de Souza, Karen Aparecida [1 ]
Vieira, Heloisa Rosa [1 ]
Fernandes, Adeline de Mira [1 ]
Compagnoli Carmona, Rita de Cassia [1 ]
Sampaio Tavares Timenetsky, Maria do Carmo [1 ]
机构
[1] Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Av Dr Arnaldo 355, BR-01246902 Sao Paulo, SP, Brazil
关键词
Rotavirus; Brazil; Gastroenteritis; Surveillance; Genotyping; Diarrhea; Vaccine; GROUP-A ROTAVIRUS; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE-SEQUENCE; POTENTIAL IMPACT; 1ST DETECTION; BUENOS-AIRES; SAO-PAULO; P-TYPE; CHILDREN; DIARRHEA;
D O I
10.1016/j.actatropica.2015.12.008
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The continuum characterization of rotavirus (RVA) genotypes is essential to understand how vaccine introduction could impact virus epidemiology. In the present study, an unexpected rapid changing pattern of RVA genotypes distribution in Brazilian population during three followed seasons is described. From January/2012 to December/2014, a total of 3441 fecal specimens were collected from collaborating centers across Southern, Southeastern and Midwest of Brazil. All specimens were screened for RVA using ELISA, and genotyped by RT-PCR. Differences in proportions were tested using Chi-Squares. A p-value of less than 0.05 was considered statistically significant. RVA was detected in 19.7% (677/3441). Among RVA positive cases (n = 677), a total of 652 (963%) samples were successfully amplified by RT-PCR. G3P[8] remained prevalent in 2012 (37.6%, 69/185) and 2013 (40.1%, 74/186) (chi(2) = 0.107, p = 0.743), but declined markedly in 2014 (3.5%,10/281) (chi(2) = 71.770,p = 0.000). G12P[8] was second highest strain in 2012 (22.7%, 42/185), decrease rapidly in 2013 (2.7%, 5/186) (chi(2) = 26.224, p = 0.000) and re-emerged as the predominant genotype in 2014 (86.6%, 243/281) (chi(2) = 118.299, p = 0.000). From July/2014, G12P[8] was the single genotype detected in all regions studied. The sudden emergence, spread and predominance of G12P[8] strain in Brazil, raised the hypothesis of a possible G12 outbreak being in progress. Nationally, the long term decline in gastroenteritis hospitalization observed in the country after RVA vaccine introduction was confirmed. Nevertheless, the sharp increase in diarrhea hospitalization prevalence from 2013 to 2014 observed in Southern and Southeastern regions is consistent with what appears to be an outbreak of G12P[8]. Continued surveillance is needed to verify the effectiveness of the RotarixTM vaccine in Brazil together with potential emergence of unusual genotypes. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 23 条
  • [21] Molecular epidemiology of rotavirus gastroenteritis in Japan during 2014-2015: Characterization of re-emerging G2P[4] after rotavirus vaccine introduction
    Khandoker, Nusrat
    Thongprachum, Aksara
    Takanashi, Sayaka
    Okitsu, Shoko
    Nishimura, Shuichi
    Kikuta, Hideaki
    Yamamoto, Atsuko
    Sugita, Kumiko
    Baba, Tsuneyoshi
    Kobayashi, Masaaki
    Hayakawa, Satoshi
    Mizuguchi, Masashi
    Ushijima, Hiroshi
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (06) : 1040 - 1046
  • [22] Multiple Introductions and Predominance of Rotavirus Group A Genotype G3P[8] in Kilifi, Coastal Kenya, 4 Years after Nationwide Vaccine Introduction
    Mwanga, Mike J.
    Verani, Jennifer R.
    Omore, Richard
    Tate, Jacqueline E.
    Parashar, Umesh D.
    Murunga, Nickson
    Gicheru, Elijah
    Breiman, Robert F.
    Nokes, D. James
    Agoti, Charles N.
    PATHOGENS, 2020, 9 (12): : 1 - 16
  • [23] Whole Genome In-Silico Analysis of South African G1P[8] Rotavirus Strains before and after Vaccine Introduction over a Period of 14 Years
    Mwangi, Peter N.
    Mogotsi, Milton T.
    Seheri, Mapaseka L.
    Mphahlele, M. Jeffrey
    Peenze, Ina
    Esona, Mathew D.
    Kumwenda, Benjamin
    Steele, A. Duncan
    Kirkwood, Carl D.
    Ndze, Valantine N.
    Dennis, Francis E.
    Jere, Khuzwayo C.
    Nyaga, Martin M.
    VACCINES, 2020, 8 (04) : 1 - 20